Israel Chemicals Ltd. (ICL) Releases Earnings Results, Hits Expectations
Israel Chemicals Ltd. (NYSE:ICL) released its quarterly earnings results on Wednesday. The company reported $0.09 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.09. The business had revenue of $1.38 billion for the quarter, compared to analysts’ expectations of $1.51 billion. Israel Chemicals had a return on equity of 17.44% and a net margin of 7.40%. The company’s revenue was up .3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.12 EPS.
Shares of Israel Chemicals (NYSE:ICL) opened at 3.80 on Thursday. The stock has a market cap of $4.84 billion, a price-to-earnings ratio of 11.99 and a beta of 1.14. Israel Chemicals has a 1-year low of $3.52 and a 1-year high of $5.23. The company has a 50-day moving average price of $3.74 and a 200-day moving average price of $3.99.
Separately, Zacks Investment Research cut Israel Chemicals from a “buy” rating to a “hold” rating in a report on Wednesday, November 2nd.
A number of institutional investors have recently modified their holdings of ICL. JPMorgan Chase & Co. boosted its position in shares of Israel Chemicals by 56.5% in the first quarter. JPMorgan Chase & Co. now owns 357,335 shares of the company’s stock worth $1,533,000 after buying an additional 129,051 shares in the last quarter. AMP Capital Investors Ltd boosted its stake in Israel Chemicals by 13.9% in the first quarter. AMP Capital Investors Ltd now owns 398,097 shares of the company’s stock worth $1,748,000 after buying an additional 48,637 shares during the period. Barclays PLC boosted its stake in Israel Chemicals by 122.1% in the first quarter. Barclays PLC now owns 85,017 shares of the company’s stock worth $340,000 after buying an additional 46,732 shares during the period. Nikko Asset Management Americas Inc. boosted its stake in Israel Chemicals by 1.2% in the second quarter. Nikko Asset Management Americas Inc. now owns 714,283 shares of the company’s stock worth $2,807,000 after buying an additional 8,800 shares during the period. Finally, Bank of Montreal Can acquired a new stake in Israel Chemicals during the second quarter worth $803,000. 6.51% of the stock is currently owned by hedge funds and other institutional investors.
Receive News & Stock Ratings for Israel Chemicals Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals Ltd. and related stocks with our FREE daily email newsletter.